The Global Human Papillomavirus (HPV) Testing Market was valued at USD 757 million in 2024 and is projected to reach USD 1,215.24 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.40% during the forecast period (2024-2032). This expansion is driven by increasing global cervical cancer screening programs, rising HPV vaccination rates, and technological breakthroughs in molecular diagnostics.
As healthcare systems worldwide prioritize early detection of HPV-related cancers, diagnostic companies are revolutionizing testing methodologies. This analysis profiles the Top 10 Companies in the HPV Testing Industry—a mix of molecular diagnostics innovators, healthcare technology leaders, and screening solution providers shaping the future of cervical cancer prevention.
🔟 10. Fujirebio Diagnostics
Headquarters: Tokyo, Japan
Key Offering: HPV E6/E7 mRNA testing systems
Fujirebio delivers cutting-edge oncoprotein detection technologies for HPV screening. Their RNA-based diagnostic solutions identify persistent high-risk HPV infections with superior specificity.
Innovation Highlights:
- Automated high-throughput HPV testing platforms
- Asia-Pacific market expansion initiatives
- CE-marked assays for European markets
Download FREE Sample Report: Human Papillomavirus (HPV) Testing Market – View in Detailed Research Report
9️⃣ 9. Arbor Vita Corporation
Headquarters: Fremont, California, USA
Key Offering: OncoE6® Cervical Test
Arbor Vita pioneered the first FDA-approved test detecting E6 oncoproteins, providing direct evidence of HPV’s carcinogenic activity. Their protein-based approach offers clinical utility in low-resource settings.
Innovation Highlights:
- WHO-prequalified point-of-care solution
- Rapid 2.5-hour test results
- Developing nations accessibility programs
8️⃣ 8. Norgen Biotek Corp.
Headquarters: Thorold, Ontario, Canada
Key Offering: HPV nucleic acid isolation kits
Norgen Biotek specializes in sample preparation technologies that enable reliable HPV detection from diverse specimen types, including self-collected samples.
Innovation Highlights:
- Stable room-temperature reagents
- Integrated self-sampling collection devices
- PCR and NGS compatibility
7️⃣ 7. Seegene Inc.
Headquarters: Seoul, South Korea
Key Offering: Anyplex™ II HPV28 Detection
Seegene’s multiplex PCR platform simultaneously identifies 28 HPV genotypes, supporting high-volume screening programs across Asia-Pacific markets.
Innovation Highlights:
- Fully automated high-capacity systems
- Multiplex genotyping technology
- Strong clinical validation studies
Download FREE Sample Report: Human Papillomavirus (HPV) Testing Market – View in Detailed Research Report
6️⃣ 6. Abbott Laboratories
Headquarters: Chicago, Illinois, USA
Key Offering: RealTime HR HPV assay
Abbott’s integrated HPV testing solution combines automated high-risk detection with partial genotyping (HPV 16/18), streamlining laboratory workflows.
Innovation Highlights:
- FDA-approved for primary screening
- Global distribution network
- Laboratory automation integration
5️⃣ 5. Thermo Fisher Scientific
Headquarters: Waltham, Massachusetts, USA
Key Offering: TaqPath™ HPV tests
Thermo Fisher’s PCR-based HPV assays leverage proprietary TaqMan technology for sensitive DNA detection, compatible with open PCR platforms.
Innovation Highlights:
- CE-marked for primary screening
- Research-use-only genotyping arrays
- Global laboratory support network
4️⃣ 4. Becton, Dickinson and Company (BD)
Headquarters: Franklin Lakes, New Jersey, USA
Key Offering: BD Onclarity™ HPV Assay
BD’s advanced platform provides extended genotyping capabilities, identifying six individual high-risk HPV types for precise risk assessment.
Innovation Highlights:
- Automated sample-to-result processing
- Integration with cytology systems
- Comprehensive risk stratification
3️⃣ 3. Hologic, Inc.
Headquarters: Marlborough, Massachusetts, USA
Key Offering: Aptima® HPV assay
Hologic’s mRNA-based test detects E6/E7 oncogene activity, offering superior specificity for clinically significant HPV infections through their Panther® system.
Innovation Highlights:
- Single-swab co-testing capability
- FDA-approved primary screening
- High-volume automation solutions
Download FREE Sample Report: Human Papillomavirus (HPV) Testing Market – View in Detailed Research Report
2️⃣ 2. Qiagen N.V.
Headquarters: Venlo, Netherlands
Key Offering: digene HC2 HPV Test
Qiagen pioneered HPV DNA testing methodology and continues leading with innovative genotyping and automation solutions through their QIAensemble platform.
Innovation Highlights:
- Clinically validated hybrid capture technology
- Emerging markets access initiatives
- Full workflow automation options
1️⃣ 1. Roche Diagnostics
Headquarters: Basel, Switzerland
Key Offering: cobas® HPV Test
Roche dominates the HPV testing landscape with their FDA-approved primary screening assay, supported by high-throughput cobas® systems for integrated diagnostic workflows.
Innovation Highlights:
- Global gold standard for HPV screening
- Comprehensive genotyping capabilities
- 6800/8800 high-capacity systems
Get Full Report Here: Human Papillomavirus (HPV) Testing Market – View in Detailed Research Report
🔬 Outlook: The Future of HPV Testing Is Precise and Accessible
The HPV diagnostics sector is undergoing transformational changes as molecular technologies advance and global screening programs expand. The industry is moving toward refined risk assessment methodologies and innovative testing solutions for diverse healthcare settings.
📈 Key Market Evolution Trends:
- Global transition from cytology to primary HPV screening
- Development of self-sampling and point-of-care solutions
- AI-powered diagnostic algorithm integration
- Combined vaccination-and-screening initiatives
The featured companies are not simply manufacturing HPV tests—they’re redefining global cervical cancer prevention strategies through technological innovation and accessibility improvements.
Get Full Report Here: Human Papillomavirus (HPV) Testing Market – View in Detailed Research Report